

Medibros Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
About Medibros Pharmaceuticals
Medibros Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 September 2021 (Three years and five months 19 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vishnu Shukla and Anand Metu serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230KA2021PTC151758
- Company No.
151758
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2021
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Medibros Pharmaceuticals?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vishnu Shukla ![]() | Managing Director | 14-Sep-2021 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anand Metu ![]() | Director | 14-Sep-2021 | Current |
Financial Performance of Medibros Pharmaceuticals.
Enhance accessibility to Medibros Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Medibros Pharmaceuticals?
Unlock access to Medibros Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Medibros Pharmaceuticals?
Medibros Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Medibros Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medibros Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Medibros Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Medibros Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
- Balance Sheet
Medibros Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore.
- Director Appointment
Vishnu Digambar Shukla was appointed as a Managing Director was appointed as a Managing Director on 14 Sep 2021 & has been associated with this company since 3 years 5 months .
- Director Appointment
Anand Metu was appointed as a Director was appointed as a Director on 14 Sep 2021 & has been associated with this company since 3 years 5 months .
- Company Incorporation
Medibros Pharmaceuticals Private Limited was registered on 14 Sep 2021 with Roc Bangalore & aged 3 years 5 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Medibros Pharmaceuticals Private Limited?
Medibros Pharmaceuticals Private Limited was incorporated on 14 Sep 2021.
What is authorized share capital and paid-up capital of Medibros Pharmaceuticals Private Limited?
The authorized share capital of Medibros Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Medibros Pharmaceuticals Private Limited?
Currently 2 directors are associated with Medibros Pharmaceuticals Private Limited.
- Vishnu Digambar Shukla
- Anand Metu
What is the registered address of Medibros Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Medibros Pharmaceuticals Private Limited is No. B3 Shreya Residency 2Nd Main 3Rd Cross Gow- Dara Colony Nagashettyhalli, - India, Bangalore, Karnataka, 560094.
What is the corporate identification number (CIN) and company number of Medibros Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Medibros Pharmaceuticals Private Limited is U24230KA2021PTC151758 and the company number is 151758 as per Ministry of Corporate Affairs (MCA).
What is the official website of Medibros Pharmaceuticals Private Limited?
The Official website of Medibros Pharmaceuticals Private Limited is https://www.medopharm.com
When was the last Balance Sheet of Medibros Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Medibros Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2022.